Home › Funds › DV EQUITIES, LLC › EPRX

DV EQUITIES, LLC position in EPRX

EUPRAXIA PHARMACEUTICALS INC · Health Care

DV EQUITIES, LLC reported holding 276,000 shares of EPRX (EUPRAXIA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$2.5M, representing 0.49% of its reported portfolio and ranking #29 among its reported holdings. DV EQUITIES, LLC has disclosed EPRX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)276.00K sh
Reported value held$2.51M
Portfolio Weight0.49%
First reportedQ2 2026
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How DV EQUITIES, LLC's EPRX position evolved

DV EQUITIES, LLC first disclosed a stake in EPRX in Q2 2026 at 276,000 shares (US$1.8M). The position peaked in Q3 2026 at 276,000 shares, worth US$2.5M. Across 2 filings, DV EQUITIES, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 276,000 shares valued at US$2.5M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 276.00K $1.82M New
Q3 2026 276.00K $2.51M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EPRX and 13F data

EPRX (EUPRAXIA PHARMACEUTICALS INC) is a Health Care company. 72 other funds we track also report a position in EPRX — the largest reported positions include Bellevue Group AG (US$23.6M), Affinity Asset Advisors, LLC (US$15.6M), Vivo Capital, LLC (US$12.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EPRX

All EPRX fund holders →

FAQ

How long has DV EQUITIES, LLC held EPRX?

DV EQUITIES, LLC has disclosed EPRX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is DV EQUITIES, LLC's current position in EPRX?

As of Q3 2026, DV EQUITIES, LLC holds 276.00K shares of EPRX (EUPRAXIA PHARMACEUTICALS INC), valued at $2.51M, representing 0.49% of its reported portfolio and ranking #29.

Has DV EQUITIES, LLC been buying or selling EPRX?

In the latest 13F filing (Q3 2026), DV EQUITIES, LLC held unchanged its position in EPRX. The position peaked in Q3 2026 at 276.00K shares.

Which other funds hold EPRX?

Other major institutional holders of EPRX include Bellevue Group AG, Affinity Asset Advisors, LLC, Vivo Capital, LLC, among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.